News and Events

Everett, Wash., Oct. 22, 2019 – Western Washington Medical Group (WWMG), a provider-owned team of physicians and providers that offers family practice and specialty services to the North Puget Sound region of Washington, has partnered with Elligo Health Research, a healthcare-enabling research organization, to add research as a care option for its more than 125,000 patients.

“Our team-oriented approach is focused on delivering personalized, patient-focused care,” said David Russian, MD, FCCP, president of WWMG. “We are fortunate to have made conducting state-of-the-art research in our office a reality through our partnership with Elligo and to now have new options for our patients who have tried all the commercially available treatments.”

As part of the partnership, Elligo will provide the tools necessary to conduct clinical research in an office setting beginning with a WWMG practice in Everett, Washington. The physicians and staff will receive specialized training, critical infrastructure, and access to novel technology that ease the burden of conducting research.

“It’s our goal to put patient needs front and center in clinical research,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “Through this partnership, we will engage a growing group of physicians and patients who would otherwise not participate in clinical research, bringing us closer to our goal of ensuring all patients have access to clinical research as a care option.”

Elligo’s IntElligo Research Stack™ clinical technology and Goes Direct® approach power the identification of patients for studies using electronic health records. And, because patients are presented with research as a care option directly from their trusted physician, Elligo’s SOAR™ model increases enrollment and retention for study sponsors, and ultimately accelerates new treatments to market.

About Western Washington Medical Group
Western Washington Medical Group, a provider-owned and run group of physicians serving the North Puget Sound region, was founded on the mission of providing state-of-the-art, evidence-based healthcare that is both cost-effective and personalized. Our team of more than 100 board-certified or board-eligible providers in 17 specialties — including cardiology, endocrinology, gastroenterology, and more — at 23 locations are dedicated to helping you make informed healthcare choices and to creating a supportive and collaborative environment that promotes improved outcomes.

Brooklyn, N.Y., July 25, 2019 – Prominis Medical Services, an outpatient medical clinic offering services across New York City, has partnered with Elligo Health Research, a healthcare-enabling research organization, to support research as a care option for its patients. The practice is currently enrolling for both a Type 2 diabetes study and a chronic obstructive pulmonary disease (COPD) study at its Bedford-Stuyvesant location on Marcus Garvey Boulevard.

“We are committed to providing New York and its surrounding communities with quality, personalized care,” said Andras Fenyves, M.D., owner and medical director at Prominis Medical Services. “We have long believed in providing care where our patients are most comfortable, and with Elligo, we now have the ability to add to our range of services, offering state-of-the-art treatment options to our patients through participation in clinical research studies right here in our own practice.”

Elligo eases the burden of conducting research by providing healthcare experts and their staff with the tools necessary to conduct clinical research in an office setting. As part of the partnership, participating practices receive specialized training, critical infrastructure, and access to novel technology.

“We’re glad to support the hard work of the physicians at Prominis Medical Services,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “Our model maintains the integrity of the trusted relationship between physicians and their patients and uses electronic health records to ensure all patients have access to clinical research as a care option.

Elligo’s IntElligo Research Stack™ clinical technology and Goes Direct® approach engages physicians and patients who would otherwise not participate in clinical research, increasing enrollment and retention for study sponsors, and ultimately accelerating new treatments to market.

 

About Prominis Medical Services

Prominis Medical Services has multiple primary care locations across Brooklyn and Queens, and our primary care physicians have been treating under the Prominis name since 2005. In addition to specialty services, patients come to us for drug and alcohol counseling, sleep studies, osteoporosis screenings, lung and nerve testing, and pain management/physical rehabilitation. Certain locations have specialists for ophthalmology, podiatry, gastroenterology, gynecology, and more. Right around the corner from you, Prominis has the health resources for you and your family.

Raleigh, N.C., July 17, 2019 – Carolina Partners Clinical Research Institute, LLC, North Carolina’s largest outpatient mental and behavioral health practice, has partnered with Elligo Health Research, a healthcare-enabling research organization, to further expand its clinical research program. The partnership makes it possible for Carolina Partners, which has 20 locations throughout North Carolina, to scale up its clinical research business beginning with its Situs Court location in Raleigh, North Carolina.

“We have long been committed to bringing additional care options to our patients through the clinical trial channel,” said Jeff Williams, CEO of Carolina Partners. “Our partnership with Elligo, together with Dr. Sandeep Vaishnavi, our clinical research director, will allow us to efficiently build a state-of-the-art clinical research facility to address the high demand for new treatments in mental health.”

Dr. Vaishnavi has been conducting research studies related to neuropsychiatric aspects of brain injury, and has developed objective methods for psychiatric assessment and management throughout his career. With multiple publications and presentations, he has been recognized regularly for his research accomplishments. Most recently, Dr. Vaishnavi was presented with the 2018 Clinical Service Award from Duke Medical Center.

Elligo eases the burden of conducting research by providing healthcare experts the tools necessary to conduct clinical research in an office setting. As part of the partnership, participating practices receive specialized training, critical infrastructure, and access to novel technology.

“We engage physicians and patients who would otherwise not participate in clinical research,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “Our IntElligo Research Stack™ clinical technology and Goes Direct® approach maintains the integrity of the trusted relationship between physicians and their patients while leveraging electronic health records to ensure all patients have access to clinical research as a care option.”

About Carolina Partners

With nearly 200,000 patient encounters in 2018, Carolina Partners in Mental HealthCare (CPMH) is one of the largest outpatient mental and behavioral healthcare services providers in the U.S. CPMH’s 150+ clinicians provide the complete spectrum of psychiatric and psychological therapeutic services to patients across 20 sites and deliver treatment for cognitive, neurological, and psychiatric disorders for patients with conditions such as dementia, ADHD, developmental disabilities, seizures, and various neurological and mood disorders.

Englewood, Colo., May 21, 2019 – The Center for Women’s Health, a medical practice focused on obstetrics and gynecology services, announces its partnership with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients. The partnership will help the Center for Women’s Health expand the treatment options it offers its patients by supporting research studies conducted in its practice. The practice is currently conducting studies in uterine fibroids and recurrent vulvovaginal candidiasis.

“Our physicians have always recognized the importance of contributing to the health and well-being of our community,” said Dr. Asela Russell, founder of the Center for Women’s Health. “But bringing Elligo’s unique, no-cost approach to clinical research into our office will allow us to contribute even more and undoubtedly help advance the future of women’s health care around the world.”

Patients at the Center for Women’s Health who have exhausted conventional methods of care can now choose to treat their conditions with cutting-edge therapies. Enabling the practice to conduct trials in-house will allow patients to stay under the care of their preferred physician and stay closer to the comforts of their own home.

“Our goal is to make clinical research easy for our participating sites,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “We want our physician partners to be able to focus solely on their patients’ care, so we provide the necessities — personnel, processes, technology, infrastructure — and communicate with patients along the way.”

About Center for Women’s Health
The Center for Women’s Health provides women in the Denver Metropolitan Area with a wide range of pre- through post-natal services that support the health and well-being of mothers and babies. The all-female medical staff understands the complex issues their patients sometimes face during pregnancy and strive to create a safe and nurturing environment. For additional information visit www.tc4w.com.

Fairfield, Ohio, May 7, 2019 – Obstetrics and Gynecology Associates, a women’s health medical practice, announced that it will now offer research as a care option through a partnership with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients.

Obstetrics and Gynecology Associates’ expansion into clinical research will help the practice’s patients benefit from treatments they might not otherwise have access to. Through the partnership, Elligo will provide the people, processes, and technology necessary for the practice to conduct trials in its office, effectively keeping patients closer to home and under the care of their trusted physician. The practice is currently conducting studies in uterine fibroids, endometriosis, and human papilloma virus (HPV).

“We are committed to serving a patient’s needs for her entire life,” said Dr. Kimberly Bonar, physician at Obstetrics and Gynecology Associates. “This partnership will help us fulfill that mission even when patients have diseases that are difficult to treat.”

“It is always an honor to help medical practices like Obstetrics and Gynecology Associates become a Research Ready study site,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “Not only are we improving their patients’ health directly, but their participation in clinical research studies helps contribute to the future of medicine as well.”

About Obstetrics and Gynecology Associates
The physicians of Obstetrics & Gynecology Associates are partners in enhancing women’s health. Since 1940, they have provided high quality, comprehensive healthcare to patients in a comfortable and caring environment. Their commitment to excellence is focused on the needs of each woman throughout all stages of life. For more information, visit www.cincyobgyn.com.

Shawnee, Kan., May 2, 2019 – WestGlen Gastrointestinal Consultants, a gastroenterology practice with 12 offices in the Kansas City metro area, is now offering research as a care option for its patients by partnering with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients.

Through the partnership, WestGlen is now a Research Ready site, which designates them as capable of conducting clinical trials in their office, providing patients the opportunity to participate in clinical research as a care option. With this designation, WestGlen’s patients will be able to benefit from novel treatments, accessed in the comfort of their trusted physician’s office. They are currently conducting studies in recurrent C. difficile, moderate to severe Crohn’s disease, moderate to severe ulcerative colitis (UC), irritable bowel syndrome (IBS), and nonalcoholic steatohepatitis (NASH).

“As a practice that addresses multiple factors such as diet, wellness, medications, and sleep patterns in patient health, we are pleased to now include clinical trials in our range of treatment plans,” said Mark A. Molos, M.D., founder and managing partner of WestGlen. “We appreciate the support and resources Elligo provides as a part of their network of study sites.”

“Elligo is delighted to be working with WestGlen to deepen the care its physicians are offering patients,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “With the addition of WestGlen to our network, we’re expanding our ability to reach more patients and advance the future of gastrointestinal care.”

About WestGlen GI Consultants
WestGlen Gastrointestinal Consultants has served the community since 1998 and is dedicated to bringing convenience and compassion to its patients. The practice specializes in Hemorrhoid Treatments (IRC and Banding), Esophagogastroduodenoscopy (EGD), Gastrointestinal Endoscopy, and Colonoscopy. For more information, visit www.westglengi.com.

Corpus Christi, Texas, Feb. 13, 2019 – Corpus Christi Women’s Clinic, a large, full-service women’s health practice in Corpus Christi, Texas, has partnered with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients. As a result of this partnership, the practice will expand the treatment options it offers patients by supporting research studies conducted in its practice.

Physicians at Corpus Christi Women’s Clinic who will be participating as lead investigators in the clinical trials include: Charles Kirkham, M.D. (FACOG); Christine L. Canterbury, M.D. (FACOG); Leighanne Glazener, M.D. (FACOG); Jaime Pena, M.D. (FACOG); Benjamin Supnet, M.D. (FACOG); Danielle Inman, M.D. (FACOG); Heather Dixon, D.O.; Thomas Wilder, M.D. (FACOG); and Lindsey Vasquez, M.D. (FACOG).

As members of Elligo’s Research Ready network, Corpus Christi Women’s Clinic now has the infrastructure — people, processes, and technology — necessary to conduct research in its office, effectively keeping patients closer to home and under the care of their trusted physician. The practice’s extension into clinical research will help its patients benefit from treatments they might not otherwise be able to access.

In a statement from Corpus Christi Women’s Clinic, the physicians explained, “We often run into scenarios where we have exhausted all traditional treatment options with our patients. Complete patient care is important to us and this partnership will help ensure we can continue to provide options for even our toughest clinical cases.”

“Our ultimate goal is twofold: to make research accessible and the process simple,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “That’s why we offer our services at no cost to our physician sites. For us, the best part is that with every new site, our ability to contribute to the future of medicine grows.”

About Corpus Christi Women’s Clinic
Corpus Christi Women’s Clinic, a large full-service women’s health physician practice serving Nueces County, opened in August of 1981. We have ten physicians. Between the ten of us, we have delivered more than 40,000 babies in our combined 100 years of experience in the Corpus Christi area. Our Womankind Services offers patients the convenience of complete OB-GYN care, including sonograms, bone density testing, and urodynamics.

Rosslyn, Va., August 2, 2018 – Advantia Health, an innovative health care company focused on the delivery of care to women, is expanding into clinical research. Patients within Advantia Health’s network will be able to access clinical research as a care option through Advantia’s partnership with Elligo Health Research, which offers the only platform that brings clinical research direct to clinical health care.

Advantia recognizes the importance of conducting clinical research for its patients and community and doing its part to advance health care around the world. Through its partnership with Elligo, Advantia’s health care practices will be able to join Elligo’s Research Ready™ network, offer their patients access to clinical research as a care option and enroll them into studies. As a result, patients will have access to state-of-the-art treatments closer to home and remain under the care of their trusted physician.

“We place women and their health care needs at the center of our innovative care delivery model and are committed to providing best-in-class health care solutions,” said Peter Glass, M.D., founder and chief medical officer at Advantia. “Our partnership with Elligo will help us deliver improved health care outcomes for our patients through better access to novel care pathways.”

“We are happy to welcome Advantia into our network of researchers,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “I can tell our infrastructure, technology and expertise will fit well into Advantia’s day-to-day work and will allow physicians to focus on patient care.”

About Advantia Health
Advantia Health is a fast-growing innovative health care company focused on women’s health and the role women play as “chief medical officer” of their families. Advantia’s Woman’s Health Hub model, which physically and clinically integrates primary care, behavioral health and other commonly utilized services into its OB/GYN practices, provides high quality coordinated services to meet women’s needs conveniently and at lower cost. Technology and an innovative care model enable Advantia physicians and allied health professionals to thrive in a fast-changing health care environment while retaining the culture and benefits of independent private practice. Learn more at www.advantiahealth.com.

 

Austin, Texas, June 21, 2018 – River Place OB/GYN, an award-winning women’s health, obstetrics and gynecology practice, announces its expansion into clinical research by partnering with Elligo Health Research, which offers the only platform that brings clinical research direct to clinical health care.

River Place OB/GYN is now offering clinical trials, allowing it to introduce the latest advances in research to its patients. As a result, the practice’s patients have access — in the convenience of the practice’s office — to treatments they might not otherwise have. River Place OB/GYN recognizes the importance of conducting clinical research for its patients and community and doing its part to advance health care around the world.

“As a women’s health practice on the forefront of medicine, we are pleased to be able to offer clinical trials as treatment options for our patients. It was Elligo’s unique approach of providing clinical trial infrastructure at no cost that made offering trials feasible,” said Rachel Shepherd, M.D., a River Place OB/GYN physician. “We appreciate the opportunity to be a part of the Elligo network.”

“We are thrilled to be working with River Place OB/GYN to advance the care its physicians are offering to patients,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “Elligo provides the personnel, processes, technology and infrastructure to facilitate the clinical research process, so the River Place team can focus on delivering high-quality care to patients.”

About River Place OB/GYN
River Place OB/GYN, a boutique obstetrics and gynecology office located in West Austin, Texas, is led by Texas-native, award winning John Thoppil, M.D. This boutique practice provides a wide variety of services — from wellness exams, weight management, birth control and full obstetric care, including high-risk pregnancies. Dr. Thoppil, along with Rachel Shepherd, M.D., and Madeleine Katz, CNM, use the latest technologies and individualized service to deliver the highest quality of care to the women of West Austin.

Austin, Texas, June 5, 2018 – Urology Austin, a urology practice with 18 offices in the Austin/Central Texas, area, has partnered with Elligo Health Research, which improves clinical trial access by engaging the 97 percent of physicians currently not offering clinical research to their patients, to offer clinical research as a care option to its patients. The partnership will allow Urology Austin to conduct clinical trials at its offices and thus provide alternative treatment options to patients who have exhausted conventional methods of care.

“We are dedicated to setting new standards in compassionate patient care,” said Dr. Carl Bischoff, urologist at Urology Austin. “And Elligo is helping us further that mission by providing the infrastructure to bring innovative, clinical trial treatments to our patients.”

Elligo’s Goes Direct^® approach makes conducting research studies easy for its physician partners. Not only does Elligo provide the necessary personnel, processes and technology to support a study, but it facilitates patient communication and takes care of many of the details, so physicians have time to focus on patient care.

“We are thrilled to welcome Urology Austin as one of our physician sites,” said John Potthoff, Ph.D., CEO of Elligo Health Research. “They are helping their patients access novel treatments closer to home and under the care of their trusted physician, and contributing to the future of urology care as well.”

 

About Urology Austin
Serving the greater Austin, Texas, area, Urology Austin seamlessly blends quality patient care with progressive thought and action, employing the latest technology and time-tested methods to help restore patient health while maintaining comfort and dignity. The region’s most respected team of urologists performs both surgical and therapeutic urologic procedures to correct problems associated with the urinary tract in men and women (the bladder and kidneys) and the genital tract, reproductive system of men. Urology Austin employs 30 of the region’s most respected and skilled urologists, including a radiation oncologist to treat bladder cancer, kidney cancer or prostate cancer. More information about Urology Austin is available at urologyaustin.com.